022 24172311
Sections
Search
DealCurry
Equity
Venture Capital
Private Equity
M&A

Capital Market | 11 January 2013

After Macquarie, Jeremy Grantham's GMO Fund Sells Stake In Sintex Ind.

by Vivek Singh
After Macquarie, Jeremy Grantham's GMO Fund Sells Stake In Sintex Ind.
Share on Social Media Email Facebook Twitter Linkedin
 
@vivek
Grantham GMO Emerging Markets, the global investment manager headed by Jeremy Grantham, sold over 15.04 lakh shares of Sintex Industries through bulk deal on NSE.

The fund manager sold the shares for R69.25 per piece aggregating to R10.42 Cr.

Latest shareholding showed GMO Emerging Markets Fund holding 2.29% stake or over 71.64 lakh shares.

IDFC Midcap Fund Acquires Stake In Innoventive Industries

IDFC Midcap Fund Acquires Stake In Innoventive Industries

IDFC Small And Midcap Fund has acquired around 3.4% stake in Innoventive Industries for R28 Cr.

Read More...

Dr Reddy's Laboratories To Acquire Select Brands From UCB India

Dr Reddy's Laboratories To Acquire Select Brands From UCB India

Telangana based Dr Reddy’s Laboratories is acquiring a select portfolio of Belgium based pharma company UCB in India for R800 Cr on a slump sale basis. The buy strengthens its presence in dermatology, respiratory and pediatrics segments.

Read More...
Subscribe
Enter your Email address
to receive all the news